Important Dates |
|
|---|---|
| Early Bird Abstract submissions Closes on March 27, 2026 | |
| Early Bird Registrations Closes on March 30, 2026 | |
| Abstract submissions Closes on September 14, 2026 | |
| Registrations Closes on September 21, 2026 | |
About Conference
Euro Cancer 2026
Welcome Message:
Prof Mohamed El-Far (Honorable Chairman).
Nobel Prize Nominate.
Mansoura University,
Egypt.
Dear colleagues,
It is my pleasure to extend a warm welcome to join our conference under title 3rd European summit on cancer and oncologists which going to be held in Berlin (Germany) during September 21 -22 , 2026. The theme (Towards a Cure: Innovations and advances in Cancer Research and Oncology).
Conference is set to unite all scientists, academics, oncologists’ professionals as well as students to convene and exchange insights at cancer research fields and its clinical applications. Besides, innovations and advancements at these various aspects.
The conference agenda will focus on critical topics and aimed the followings:
1. To show and discuss novel research trends and strategies of technological innovation in cancer therapies.
2. To discuss several key issues that greatly affect treatments of different types of cancer.
3. To refocus vision not only for cancer research innovations but also to present key challenges in cancer management in different directions as:
• New prevention protocols
• Novel ways for early detection
• Search for more safer effective modalities
• promotion of scientific collaboration as well as facilitating knowledge sharing between scientists, medical doctors and companies as an ultimate goal of our conference.
As Honorable Chairman we do welcome all of you to join our conference to be a part of shaping a better future in this field. You are most welcome to join us in beautiful city Berlin.
After the successful completion of two remarkable editions, Times Scientific Group is delighted to invite you to 3rd European summit on Cancer Research and Oncologists – Euro Cancer 2026, scheduled to take place on September 21-22, 2026 in Berlin, Germany.
Euro Cancer 2026 conference will bring together leading oncologists, healthcare professionals, renowned scientists, pioneering researchers, academicians, and industry leaders - top delegates from across the globe to foster knowledge exchange, ignite innovation, and advance cancer research and clinical oncology.
This conference serves as a global platform to spotlight the most recent breakthroughs in cancer biology, diagnostic advancements, therapeutic strategies, and personalized medicine, immuno-oncology, targeted therapies, precision medicine, AI in oncology, and personalized treatment approaches. With cancer remaining one of the world’s leading causes of mortality, this event provides an essential opportunity to discuss novel diagnostic tools, clinical trial outcomes, emerging therapeutics, patient-centered care models, and the implementation of multidisciplinary strategies across the continuum of cancer care.
Key topics will include cutting-edge research on tumor microenvironment, biomarkers, cancer genomics, early detection methods, and the integration of artificial intelligence in oncology diagnostics and treatment planning. Special sessions will also focus on the management of prevalent and rare cancers, pediatric oncology, cancer prevention, survivorship, and the aspects of oncology care.
With the rapid evolution of precision oncology and immuno-oncology, this conference will spotlight innovations such as CAR-T cell therapy, cancer vaccines, liquid biopsies, and novel drug delivery systems. Discussions will also emphasize the challenges and opportunities in global cancer care, particularly in European healthcare systems, highlighting disparities and strategies for equitable access to advanced treatments.
Why Berlin?
Berlin, the dynamic capital of Germany, stands as a hub of scientific excellence, innovation, and collaboration. Known for its world-class research institutions, thriving biotech and healthcare sectors, and strong academic network, Berlin provides the ideal setting for a global cancer research summit. The city’s rich history, cultural diversity, and commitment to scientific progress make it a vibrant venue for meaningful exchange and discovery. With its state-of-the-art conference facilities and exceptional connectivity, Berlin offers an inspiring environment for professionals to network, share ideas, and forge new collaborations that drive the future of oncology.
Visa & Travel Assistance:
All registered international participants will receive an official invitation letter to assist with their visa application.We recommend submitting applications early to ensure timely processing and smooth travel. Register early for the conference to secure your spot and enjoy all sessions, networking opportunities, and conference benefits without any hassle.
We look forward to welcoming you to Germany in September 2026 for an inspiring and impactful gathering. Together, let’s advance the frontier of cancer and oncology research and treatment for a healthier tomorrow.
Conference Highlights – Euro Cancer 2026
• Lectures by Active Investigators
• Keynote Forums by Renowned Speakers
• Speaker Presentations
• Poster Sessions on the Latest Innovations across Relevant Fields
• Panel Discussions and Interactive Sessions
• Open Innovation Challenges
• Poster Sessions for All Career Stages
• Post-Doctoral Career Development Session
• Young Researchers Forum (YRF)
• B2B Meetings
• Global Networking with Delegates from 50+ Countries
• Novel Techniques to Support and Enhance Research
• Best Platform for Global Business and Networking Opportunities
• Excellent Opportunity to Showcase the Latest Products in Oncology and Allied Fields
Session Highlights:
- Cancer & Oncology
- Types and Causes of Cancer
- Medical Oncology
- Surgical Oncology
- Radiation Oncology
- Gynaecological cancer
- Molecular Oncology
- Neuro-Oncology
- Pediatric Oncology & Oncology Nutrition
- Breast Cancer
- Oncology Nursing
- Cancer Genetics and Genomics
- Colorectal Cancer
- Prostate Cancer
- Hematological Oncology
- Interventional Oncology
- Gastrointestinal cancer
- Blood Cancers (Leukemia, Lymphoma, Myeloma)
- Cancer Treatment and Therapeutics
- Cancer Immunology & Immunotherapy
- Cancer Biomarkers
- Cancer Tumors
- Oncogenomics & Oncoproteomics
- Radiotherapy
- Hepatocellular Carcinoma
- Chemotherapy
- Personalized & Translational Oncology
- Clinical trials & in Oncology
- Stem Cell, Gene Therapy and CAR-T Cell Therapy
- Antibody-Drug Conjugates (ADCs)
- Uro-Oncology
- Oral Oncology
- Gastrointestinal Oncology
- Cancer Epidemiology
- Precision Oncology
- Personalised Cancer Therapy
- COVID-19 and Its Impact on Cancer
- Cancer Screening, Imaging and Diagnosis
- Artificial Intelligence in Cancer Research
- Other Emerging Topics in Oncology
Past Conference Highlights :
• World Congress on Clinical Oncology (Oncology 2024) – October 03-04, 2024 at City Seasons Suites, Dubai, UAE.
Theme: Innovations and Progress in Comprehensive Cancer Therapeutics
This conference gathered experts to share the latest advancements in cancer treatment. It focused on new therapies and personalized medicine. Attendees learned about improved diagnostic techniques. The event encouraged collaboration to improve cancer care worldwide.
• 2nd Global Conference on Clinical Oncology (Clinical Oncology 2025) – September 18-19, 2025 at Hotel Mystays Ochanomizu Conference Center, Tokyo, Japan.
Theme: Pioneering a New Era in Cancer Therapy: Hope, Innovation, and Care
This event highlighted the newest developments in cancer care and clinical research. It covered breakthroughs in treatments and patient care strategies. Leading doctors from Asian countries like Japan, China, Russia discussed how to make cancer therapy more effective. The conference aimed to inspire innovation and hope in cancer treatment.
Building on the tremendous success of Oncology 2024 and Clinical Oncology 2025, we are delighted to announce the upcoming 3rd European Summit on Cancer Research and Oncologists.
The 3rd European Summit on Cancer and Oncologists brings together individuals and organizations committed to advancing oncology research and enhancing cancer care, including:
• Cancer Researchers
• Oncologists
• Doctors, Scientists & Experts
• Medical Professionals
• Research Scholars
• Industry Leaders
• Business Delegates
• Oncology Surgeons
• Cancer Specialists & Subspecialists
• Clinical Researchers and Principal Investigators
• Postgraduate Researchers, Academicians & Medical Students
• Academicians, Professors & Postgraduate Students
• Postdoctoral Fellows and Young Investigators
• University Researchers
• Medical Students, Research Institutes & Training Centers
• Clinical Trial Coordinators & CRO Representatives
• Patient Advocates, Survivorship Program Leaders & NGOs
• Industry professionals in medical devices, pharmaceuticals, diagnostics
• Public Health Experts, Policy Makers & Administrators
• Representatives from Cancer & Oncology Societies, Associations & Foundations
• Healthcare Professionals from Related Disciplines
Only Registration Fee includes (Academic, Business & Students)
Free access to all lectures in single event
Tea & Coffee break during the event dates
Lunch during the conference
Abstract book & Event gadgets
Single complimentary paper abstract (For Speakers & Poster's)
Certificate of Presentation
For registration please click Slot Booking
Cancer Market Analysis in the US, Europe & Asia for 2024–2025
United States:
• The U.S. cancer therapeutics and oncology market was valued at approximately USD 208 billion in 2024 and is projected to reach USD 226 billion in 2025, growing at a CAGR of ~8.7% from 2025 to 2034.
• The U.S. oncology drugs market is expected to grow from USD 88.7 billion in 2024 to USD 128.9 billion by 2034, reflecting high adoption of immunotherapies, targeted therapies, and precision oncology.
Europe:
• The European cancer therapeutics market was valued at USD 58–63 billion in 2024–2025 and is anticipated to grow at a CAGR of ~4.4% from 2025 to 2034, supported by universal healthcare, screening programs, and adoption of targeted therapies.
• The European oncology drugs market generated USD 56.2 billion in 2024 and is expected to grow steadily through 2030.
Asia:
• The Asian (Asia-Pacific) cancer therapeutics market was valued at approximately USD 54–59 billion in 2024–2025 and is projected to grow at a CAGR of ~7–8% through 2034, driven by rising cancer incidence and expanding healthcare infrastructure.
• The oncology drugs market in Asia generated USD 39–45 billion in 2024 and is expected to grow at a CAGR of ~6–7% from 2024 to 2030.
